BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20019695)

  • 1. ABC transporters in drug-refractory epilepsy: limited clinical significance of pharmacogenetics?
    Cascorbi I
    Clin Pharmacol Ther; 2010 Jan; 87(1):15-8. PubMed ID: 20019695
    [No Abstract]   [Full Text] [Related]  

  • 2. RLIP76 in AED drug resistance.
    Janigro D; Awasthi S; Awasthi YC; Sharma R; Yadav S; Singhal SS; Hallene K
    Epilepsia; 2007 Jun; 48(6):1218-9; author reply 1219-20. PubMed ID: 17553125
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical reappraisal of the influence of drug-transporter polymorphisms in epilepsy.
    Orlandi A; Paolino MC; Striano P; Parisi P
    Expert Opin Drug Metab Toxicol; 2018 May; 14(5):505-512. PubMed ID: 29804481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of support for a role for RLIP76 (RALBP1) in response to treatment or predisposition to epilepsy.
    Soranzo N; Kelly L; Martinian L; Burley MW; Thom M; Sali A; Kroetz DL; Goldstein DB; Sisodiya SM
    Epilepsia; 2007 Apr; 48(4):674-83. PubMed ID: 17437410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [ABC transporters and drug resistance in epilepsy: biological plausibility, pharmacogenetics and precision medicine].
    Riquelme-Alcázar J; González-Vargas R; Moya PR
    Rev Neurol; 2020 Jan; 70(1):23-32. PubMed ID: 31845753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ABC transporters during epilepsy and mechanisms underlying multidrug resistance in refractory epilepsy.
    Lazarowski A; Czornyj L; Lubienieki F; Girardi E; Vazquez S; D'Giano C
    Epilepsia; 2007; 48 Suppl 5():140-9. PubMed ID: 17910594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug resistance in epilepsy: a pharmacogenomic update.
    Tate SK; Sisodiya SM
    Expert Opin Pharmacother; 2007 Jul; 8(10):1441-9. PubMed ID: 17661727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research Progress on the Role of ABC Transporters in the Drug Resistance Mechanism of Intractable Epilepsy.
    Xiong J; Mao DA; Liu LQ
    Biomed Res Int; 2015; 2015():194541. PubMed ID: 26491660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenomics in the treatment of epilepsy.
    Clancy CE; Kass RS
    Pharmacogenomics; 2003 Nov; 4(6):747-51. PubMed ID: 14596638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining the clinical role of pharmacogenetics in antiepileptic drug therapy.
    Dlugos DJ; Buono RJ; Ferraro TN
    Pharmacogenomics J; 2006; 6(6):357-9. PubMed ID: 16505830
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of Neuroinflammation on ABC Transporters: Possible Contribution to Refractory Epilepsy.
    Deng X; Xie Y; Chen Y
    CNS Neurol Disord Drug Targets; 2018; 17(10):728-735. PubMed ID: 30152292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epilepsy pharmacogenetics : science or fiction?].
    Depondt C
    Med Sci (Paris); 2013 Feb; 29(2):189-93. PubMed ID: 23452606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Oxidative Stress on ABC Transporters: Contribution to Epilepsy Pharmacoresistance.
    Grewal GK; Kukal S; Kanojia N; Saso L; Kukreti S; Kukreti R
    Molecules; 2017 Feb; 22(3):. PubMed ID: 28264441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of common variation in drug transporter genes in refractory epilepsy.
    Soranzo N; Goldstein DB; Sisodiya SM
    Expert Opin Pharmacother; 2005 Jul; 6(8):1305-12. PubMed ID: 16013981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetics and the treatment of epilepsy: what do we know?
    Božina N; Sporiš IŠ; Božina T; Klarica-Domjanović I; Tvrdeić A; Sporiš D
    Pharmacogenomics; 2019 Oct; 20(15):1093-1101. PubMed ID: 31588875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic association studies in epilepsy pharmacogenomics: lessons learnt and potential applications.
    Depondt C; Shorvon SD
    Pharmacogenomics; 2006 Jul; 7(5):731-45. PubMed ID: 16886898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on pharmacogenetics in epilepsy: a brief review.
    Szoeke CE; Newton M; Wood JM; Goldstein D; Berkovic SF; OBrien TJ; Sheffield LJ
    Lancet Neurol; 2006 Feb; 5(2):189-96. PubMed ID: 16426995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-speed screening of human ATP-binding cassette transporter function and genetic polymorphisms: new strategies in pharmacogenomics.
    Ishikawa T; Sakurai A; Kanamori Y; Nagakura M; Hirano H; Takarada Y; Yamada K; Fukushima K; Kitajima M
    Methods Enzymol; 2005; 400():485-510. PubMed ID: 16399366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Polymorphism of ABCB1 and ABCG2 genes encoding drug transporters and their investigation by pyrosequencing].
    Dribnokhodova OP; Mironov KO; Dunaeva EA; Shipulin GA
    Eksp Klin Farmakol; 2012; 75(10):29-36. PubMed ID: 23240156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PharmGKB submission update: IV. PMT submissions of genetic variations in ATP-Binding cassette transporters to the PharmGKB network.
    Nguyen TD; Gow JM; Chinn LW; Kelly L; Jeong H; Huang CC; Stryke D; Kawamoto M; Johns SJ; Carlson E; Taylor T; Ferrin TE; Sali A; Giacomini KM; Kroetz DL
    Pharmacol Rev; 2006 Mar; 58(1):1-2. PubMed ID: 16507877
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.